These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22500046)

  • 1. Severe metabolic acidosis in a newborn with an abnormal newborn screen.
    Schrier SA; Ficicioglu C
    Clin Pediatr (Phila); 2012 May; 51(5):518-20. PubMed ID: 22500046
    [No Abstract]   [Full Text] [Related]  

  • 2. A neonatal death due to medium-chain acyl-CoA dehydrogenase deficiency: utilization of the neonatal metabolic screen in a functional approach to sudden unexplained infant death.
    Manoukian AA; Ha CE; Seaver LH; Bhagavan NV
    Am J Forensic Med Pathol; 2009 Sep; 30(3):284-6. PubMed ID: 19696588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium-chain acyl-CoA dehydrogenase deficiency: a case presentation.
    Moore DJ
    Neonatal Netw; 2005; 24(5):7-13. PubMed ID: 16279050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal ventricular tachyarrhythmias in medium chain acyl-CoA dehydrogenase deficiency.
    Yusuf K; Jirapradittha J; Amin HJ; Yu W; Hasan SU
    Neonatology; 2010; 98(3):260-4. PubMed ID: 20414003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sweet and sour aspects of medium-chain acyl CoA dehydrogenase deficiency. Commentary on K. Yusuf et al.: Neonatal ventricular tachyarrhythmias in medium chain acyl-CoA dehydrogenase deficiency (Neonatology 2010;98:260-264).
    Derks TG
    Neonatology; 2010; 98(3):265-7. PubMed ID: 20414004
    [No Abstract]   [Full Text] [Related]  

  • 6. Newborn screening for medium chain acyl CoA dehydrogenase deficiency.
    Leonard JV; Dezateux C
    Arch Dis Child; 2009 Mar; 94(3):235-8. PubMed ID: 18838415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neonatal screening for metabolic diseases: need for efficacy studies].
    Williams M
    Ned Tijdschr Geneeskd; 2008 Jul; 152(30):1653-6. PubMed ID: 18714517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended newborn screening: an update for the general paediatrician.
    Coman D; Bhattacharya K
    J Paediatr Child Health; 2012 Feb; 48(2):E68-72. PubMed ID: 22017206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) in the UK.
    Goddard P
    J Fam Health Care; 2004; 14(4):90-2. PubMed ID: 15453442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvements to the newborn bloodspot screening service are required to meet national standards.
    Bello S; Ferguson C; Wallis R
    J Med Screen; 2010; 17(3):114-20. PubMed ID: 20956720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vacuolation of neutrophils and acanthocytosis in child with medium chain acyl-CoA dehydrogenase deficiency.
    Lainey E; Ogier H; Fenneteau O
    Br J Haematol; 2008 Mar; 140(6):595. PubMed ID: 18215202
    [No Abstract]   [Full Text] [Related]  

  • 12. The Addition of MCADD to the Newborn Blood Spot Screening Programme.
    Ryan H; Crushell E; Boyle MA
    Ir Med J; 2019 Sep; 112(8):995. PubMed ID: 31651112
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of neonatal screening for medium chain acyl-CoA dehydrogenase deficiency: the homogeneous population of The Netherlands.
    van der Hilst CS; Derks TG; Reijngoud DJ; Smit GP; TenVergert EM
    J Pediatr; 2007 Aug; 151(2):115-20, 120.e1-3. PubMed ID: 17643759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonates at risk of medium-chain acyl-CoA dehydrogenase deficiency: a perinatal protocol for use before population neonatal screening test results become available.
    van Rijt WJ; Jager EA; van Spronsen FJ; de Koning T; Heiner-Fokkema MR; Derks TG
    Genet Med; 2016 Dec; 18(12):1322-1323. PubMed ID: 27657689
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuropsychological functioning in children with medium chain acyl coenzyme a dehydrogenase deficiency (MCADD): the impact of early diagnosis and screening on outcome.
    Joy P; Black C; Rocca A; Haas M; Wilcken B
    Child Neuropsychol; 2009 Jan; 15(1):8-20. PubMed ID: 18608229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare use and costs of medium-chain acyl-CoA dehydrogenase deficiency in Australia: screening versus no screening.
    Haas M; Chaplin M; Joy P; Wiley V; Black C; Wilcken B
    J Pediatr; 2007 Aug; 151(2):121-6, 126.e1. PubMed ID: 17643760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of the most common medium-chain acyl CoA dehydrogenase (MCAD) deficiency mutation (K329E) in the Czech newborn population.
    Kozàk L; Hrabincovà E; Rudolfoà J; Vràbelovà S; Freiberger T
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():49-50. PubMed ID: 11400780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infant coma in the emergency department: 2 cases of MCAD deficiency].
    Hoflack M; Caruba C; Pitelet G; Haas H; Mas JC; Paquis V; Berard E
    Arch Pediatr; 2010 Jul; 17(7):1074-7. PubMed ID: 20434892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medium-chain acyl-CoA-dehydrogenase (MCAD) deficiency: French consensus for neonatal screening, diagnosis, and management].
    Feillet F; Ogier H; Cheillan D; Aquaviva C; Labarthe F; Baruteau J; Chabrol B; de Lonlay P; Valayanopoulos V; Garnotel R; Dobbelaere D; Briand G; Jeannesson E; Vassault A; Vianey-Saban C;
    Arch Pediatr; 2012 Feb; 19(2):184-93. PubMed ID: 22244319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep induced abnormal motor behaviors caused by medium-chain acyl-CoA dehydrogenase deficiency: a case report.
    Meng X; Mao W; Sun W; Li L; Zhan S; Wu X; Huang Z; Zhang X; Ma Y; Wang Y
    Sleep Med; 2012 Jan; 13(1):115-7. PubMed ID: 22137110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.